Adenosine receptor activation and nociception

European Journal of Pharmacology

Volumn 347, Issue 1, 1998, Pages 1-11

  Sawynok, Jana ^a  

^a DALHOUSIE UNIVERSITY   (Canada)

Author keywords

Adenosine; Antinociception; Caffeine; Pain

Indexed keywords

ADENOSINE RECEPTOR;

CALCIUM CELL LEVEL; DRUG EFFECT; HUMAN; HUMAN CELL; MAST CELL; NERVE ENDING; NEUROTRANSMISSION; NOCICEPTION; PAIN; PERIPHERAL NERVE; PRESYNAPTIC INHIBITION; PRIORITY JOURNAL; RECEPTOR UPREGULATION; REVIEW; SENSORY NERVE;

EID: 0032540196     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(97)01605-1     Document Type: Article

References (152)

1. 6-(R-phenylisopropyl)-adenosine (PIA) and caffeine on nociception and morphine-induced analgesia, tolerance and dependence in mice. Eur. J. Pharmacol. 112:1985;171-179.
2. 1 adenosine receptor expressed in chinese hamster ovary cells not only inhibits cAMP accumulation but also stimulates phospholipase C and arachidonate release. Mol. Pharmacol. 45:1994;1036-1042.
3. 1 antinociception, tolerance and withdrawal. J. Neurosci. 17:1997;735-744.
4. Aran S., Proudfit H.K. Antinociception produced by interactions between intrathecally administered adenosine agonists and norepinephrine. Brain Res. 513:1990;255-263.
5. Aran S., Proudfit H.K. Antinociceptive interactions between intrathecally administered α noradrenergic agonists and 5′-N-ethylcarboxamide adenosine. Brain Res. 519:1990;287-293.
6. Belfrage M., Sollevi A., Segerdahl M., Sjölund K.-F., Hansson P. Systemic adenosine infusion alleviates spontaneous and stimulus evoked pain in patients with peripheral neuropathic pain. Anesth. Analg. 81:1995;713-717.
7. Bertolet B., Belardinelli L., Hill J.A. Absence of adenosine-induced chest pain after total cardiac afferent denervation. Am. J. Cardiol. 72:1993;483-484.
8. Bleehen T., Keele C.A. Observations on the algogenic actions of adenosine compounds on the human blister base preparation. Pain. 3:1977;367-377.
9. Burke S.P., Nadler J.V. Regulation of glutamate and aspartate release from slices of the hippocampal CA1 area: Effects of adenosine and baclofen. J. Neurochem. 51:1988;1541-1551.
10. Burnstock G., Wood J.N. Purinergic receptors: Their role in nociception and primary afferent neurotransmission. Curr. Opin. Neurobiol. 6:1996;526-532.
11. Cahill C.M., White T.D., Sawynok J. Spinal opioid receptors and adenosine release: Neurochemical and behavioural characterization of opioid subtypes. J. Pharmacol. Exp. Ther. 275:1995;84-93.
12. Calignano A., Persico P., Mancuso F., Sorrentino L. Adenosine release in morphine-induced hypotension in rats. Gen. Pharmac. 23:1992;7-10.
13. Castañeda-Hernández G., Castillo-Méndez M.S., López-Muñoz F.J., Granados-Soto V., Flores-Murrieta F.J. Potentiation by caffeine of the analgesic effect of aspirin in the pain-induced functional impairment model in the rat. Can. J. Physiol. Pharmacol. 72:1994;1127-1131.
14. 2 adenosine receptors in the rat spinal cord. J. Pharmacol. Exp. Ther. 242:1987;905-910.
15. 2 receptors of the substantia gelatinosa are located predominantly on intrinsic neurons: An autoradiographic study. J. Pharmacol. Exp. Ther. 247:1988;757-764.
16. Collier H.O.J., James G.W.L., Schneider C. Antagonism by aspirin and fenamates of bronchoconstriction and nociception induced by adenosine 5′-triphosphate. Nature. 5060:1966;411-412.
17. Contreras E., Germany A., Villar M. Effects of some adenosine analogs on morphine-induced analgesia and tolerance. Gen. Pharmac. 21:1990;763-767.
18. Corradetti R., Lo Conte G., Moroni F., Passani M.B., Pepeu G. Adenosine decreases aspartate and glutamate release from rat hippocampal slices. Eur. J. Pharmacol. 104:1984;19-26.
19. Crawley J.N., Patel J., Marangos P.J. Behavioral characterization of two long-lasting adenosine analogs: Sedative properties and interaction with diazepam. Life Sci. 29:1981;2623-2630.
20. Crea, F., Galassi, A.R., Kaski, J.C., Pupita, G., El Tamimi, H., Davies, G.J., Maseri, A., 1989. Effect of theophylline on exercise-induced myocardial ischaemia. Lancet, 683-686.
21. Crea F., Pupita G., Galassi A.R., El-Tamimi H., Kaski J.C., Davies G., Maseri A. Role of adenosine in pathogenesis of anginal pain. Circulation. 81:1990;164-172.
22. Crea F., Gaspardone A., Kaski J.C., Davies G., Maseri A. Relation between stimulation site of cardiac afferent nerves by adenosine and distribution of cardiac pain: Results of a study in patients with stable angina. J. Am. Coll. Cardiol. 20:1992;1498-1502.
23. Cronstein B.N. Adenosine, an endogenous anti-inflammatory agent. J. Appl. Physiol. 76:1994;5-13.
24. Cronstein B.N. A novel approach to the development of anti-inflammatory agents: Adenosine release at inflamed sites. J. Invest. Med. 43:1995;50-57.
25. Cronstein B.N., Naime D., Firestein G. The anti-inflammatory effects of an adenosine kinase inhibitor are mediated by adenosine. Arth. Rheum. 38:1995;1040-1045.
26. Cui J.-G., Sollevi A., Linderoth B., Meyerson B.A. Adenosine receptor activation suppresses hypersensitivity and potentiates spinal cord stimulation in mononeuropathic rats. Neurosci. Lett. 223:1997;173-176.
27. DeLander G.E., Hopkins C.J. Spinal adenosine modulates descending antinociceptive pathways stimulated by morphine. J. Pharmacol. Exp. Ther. 239:1986;88-93.
28. 2 adenosine receptors in spinal mechanisms of antinociception. Eur. J. Pharmacol. 139:1987;215-223.
29. DeLander G.E., Keil G.J. Antinociception induced by intrathecal coadministration of selective adenosine receptor and selective opioid receptor agonists. J. Pharmacol. Exp. Ther. 268:1994;943-951.
30. DeLander G.E., Wahl J.J. Behavior induced by putative nociceptive neurotransmitters is inhibited by adenosine or adenosine analogs coadministered intrathecally. J. Pharmacol. Exp. Ther. 246:1988;565-570.
31. DeLander G.E., Wahl J.J. Morphine (intracerebroventricular) activates spinal systems to inhibit behavior induced by putative pain neurotransmitters. J. Pharmacol. Exp. Ther. 251:1989;1090-1095.
32. DeLander G.E., Wahl J.J. Descending systems activated by morphine (ICV) inhibit kainic acid (IT)-induced behavior. Pharmacol. Biochem. Behav. 39:1991;155-159.
33. De Montis M.G., Devoto P., Meloni D., Saba P.L., Tagliamonte A. Decreased adenosine A2 receptor function in morphine dependent rats. Pharmacol. Res. 25 (Suppl. 2):1992;232-233.
34. Dibner-Dunlap M.E., Kinugawa T., Thames M.D. Activation of cardiac sympathetic afferents: Effects of exogenous adenosine and adenosine analogues. Am. J. Physiol. 265:1993;H395-H400.
35. Doak G.J., Sawynok J. Complex role of peripheral adenosine in the genesis of the response to subcutaneous formalin in the rat. Eur. J. Pharmacol. 281:1995;311-318.
36. Doi T., Kuzuna S., Maki Y. Spinal antinociceptive effects of adenosine compounds in mice. Eur. J. Pharmacol. 137:1987;227-231.
37. Dray A. Inflammatory mediators of pain. Br. J. Anaesth. 75:1995;125-131.
38. Ekblom A., Segerdahl M., Sollevi A. Adenosine increases the cutaneous heat pain threshold in healthy volunteers. Acta Anaesthesiol. Scand. 39:1995;717-722.
39. Eschalier A., Mestre C., Dubray C., Ardid D. Why are antidepressants effective as pain relief? CNS Drugs. 2:1994;261-267.
40. Fastbom J., Post C., Fredholm B.B. Antinociceptive effects and spinal distribution of two adenosine receptor agonists after intrathecal administration. Pharmacol. Toxicol. 66:1990;69-72.
41. Forbes J.A., Beaver W.T., Jones K.F., Kehm C.J., Smith W.K., Gongloff C.M., Zeleznock J.R., Smith J.W. Effect of caffeine on ibuprofen analgesia in postoperative oral surgery pain. Clin. Pharm. Ther. 49:1991;674-684.
42. Fredholm B.B. Adenosine, adenosine receptors and the actions of caffeine. Pharmacol. Toxicol. 76:1995;93-101.
43. Fredholm B.B., Vernet L. Morphine increases depolarization induced purine release from rat cortical slices. Acta Physiol. Scand. 104:1978;502-504.
44. Fredholm B.B., Abbracchio M.P., Burnstock G., Daly J.W., Harden T.K., Jacobson K.A., Leff P., Williams M. Nomenclature and classification of purinoceptors. Pharmacol. Rev. 46:1994;143-156.
45. Gaspardone A., Crea F., Tomai F., Iamele M., Crossman D.C., Pappagallo M., Versaci F., Chiariello L., Gioffrè P.A. Substance P potentiates the algogenic effects of intraarterial infusion of adenosine. J. Am. Coll. Cardiol. 24:1994;477-482.
46. 1 receptors. J. Am. Coll. Cardiol. 25:1995;251-257.
47. Geiger J.D., LaBella F.S., Nagy J.I. Characterization and localization of adenosine receptors in rat spinal cord. J. Neurosci. 4:1984;2303-2310.
48. Germany A., Villar M., Quijada L., Contreras E. Influence of adenosine analogs on morphine tolerance and dependence in mice. Cell. Mol. Biol. 36:1990;409-414.
49. Ghelardini G., Galeotti N., Bartolini A. Caffeine induces central cholinergic analgesia. Naunyn-Schmiedeberg's Arch. Pharmacol. 356:1997;590-595.
50. 3H ]cyclohexyladenosine J. Neurosci. 2:1982;1230-1241.
51. Gourley D.R.H., Beckner S.K. Antagonism of morphine analgesia by adenine, adenosine, and adenine nucleotides. Proc. Soc. Exp. Biol. Med. 144:1973;774-778.
52. Granados-Soto V., López-Muñoz F.J., Castañeda-Hernández G., Salazar L.A., Villarreal J.E., Flores-Murrieta F.J. Characterization of the analgesic effects of paracetamol and caffeine combinations in the pain-induced functional impairment model in the rat. J. Pharm. Pharmacol. 45:1993;627-631.
53. Guieu R., Peragut J.C., Roussel P., Hassani H., Sampieri F., Bechis G., Gola R., Rochat H. Adenosine and neuropathic pain. Pain. 68:1996;271-274.
54. Herrick-Davis K., Chippari S., Luttinger D., Ward S.J. Evaluation of adenosine agonists as potential analgesics. Eur. J. Pharmacol. 162:1989;365-369.
55. Hill S.J. Distribution, properties and functional characteristics of three classes of histamine receptor. Pharmacol. Rev. 42:1990;45-83.
56. Ho I.K., Loh H.H., Leong Way E. Cyclic adenosine monophosphate antagonism of morphine analgesia. J. Pharmacol. Exp. Ther. 185:1973;336-346.
57. Holmgren M., Hedner J., Mellstrand T., Nordberg G., Hedner T. Characterization of the antinociceptive effects of some adenosine analogues in the rat. Naunyn-Schmiedebergs Arch. Pharmacol. 334:1986;290-293.
58. Hoyer D., Clarke D.E., Fozard J.R., Hartig P.R., Martin G.R., Mylecharane E.J., Saxena P.R., Humphrey P.P.A. International union of pharmacology classification of receptors for 5-hydroxytryptamine (serotonin). Pharmacol. Rev. 46:1994;157-203.
59. Huang M.H., Sylvén C., Horackova M., Armour J.A. Ventricular sensory neurons in canine dorsal root ganglia: Effects of adenosine and substance P. Am. J. Physiol. 269 (Regulatory Integrative Comp. Physiol. 38):1995;R318-R324.
60. Hunskaar S., Post C., Fasmer O.B., Arwestrom E. Intrathecal injection of capsaicin can be used as a behavioural nociceptive test in mice. Neuropharmacology. 25:1986;1149-1153.
61. Jonzon B., Sylvén C., Kaijser L. Theophylline decreases pain in the ischaemic forearm test. Cardiovasc. Res. 9:1989;807-809.
62. Jurna I. Cyclic nucleotides and aminophylline produce different effects on nociceptive motor and sensory responses in the rat spinal cord. Naunyn-Schmiedebergs Arch. Pharmacol. 327:1984;23-30.
63. Kaplan G.B., Leite-Morris K.A. Up-regulation of adenosine transporter-binding sites in striatum and hypothalamus of opiate tolerant mice. Brain Res. 763:1997;215-220.
64. 1 receptors in morphine dependence. Brain Res. 657:1994;347-350.
65. 1-selective adenosine agonist abolishes allodynia elicited by vibration and touch after intrathecal injection. Anesth. Analg. 50:1995;844-847.
66. Karlsten R., Gordh T., Hartvig P., Post C. Effects of intrathecal injection of the adenosine receptor agonists R-phenylisopropyl-adenosine and N-ethylcarboxamide-adenosine on nociception and motor function in the rat. Anesth. Analg. 71:1990;60-64.
67. 1-adenosine receptor. Neurosci. Lett. 121:1991;267-270.
68. Karlsten R., Gordh T., Post C. Local antinociceptive and hyperalgesic effects in the formalin test after peripheral administration of adenosine analogues in mice. Pharmacol. Toxicol. 70:1992;434-438.
69. Keele, C.A., Armstrong, D., 1964. Substances Producing Pain and Itch. Williams and Wilkins, Baltimore, MD, pp. 124-151.
70. Keil G.J. II, DeLander G.E. Spinally-mediated antinociception is induced in mice by an adenosine kinase-, but not by an adenosine deaminase-inhibitor. Life Sci. 51:1992;171-176.
71. Keil G.J., DeLander G.E. Adenosine kinase and adenosine deaminase inhibition modulate spinal adenosine- and opioid agonist-induced antinociception in mice. Eur. J. Pharmacol. 271:1994;37-46.
72. Keil G.J., DeLander G.E. Altered sensory behaviours in mice following manipulation of endogenous spinal adenosine neurotransmission. Eur. J. Pharmacol. 312:1996;7-14.
73. Khasar S.G., Wang J.-F., Taiwo Y.O., Heller P.H., Green P.G., Levine J.D. Mu-opioid agonist enhancement of prostaglandin-induced hyperalgesia in the rat: A G-protein βγ subunit-mediated effect? Neuroscience. 67:1995;189-195.
74. Lagerqvist B., Sylvén C., Theodorsen E., Kaijser L., Helmius G., Waldenström A. Adenosine induced chest pain: A comparison between intracoronary bolus injection and steady state infusion. Cardiovasc. Res. 26:1992;810-814.
75. Laska E.M., Sunshine A., Mueller F., Elvers W.B., Siegel C., Rubin A. Caffeine as an analgesic adjuvant. J. Am. Med. Assoc. 251:1984;1711-1718.
76. Lee Y.-W., Yaksh T.L. Pharmacology of the spinal adenosine receptor which mediates the antiallodynic action of intrathecal adenosine agonists. J. Pharmacol. Exp. Ther. 277:1996;1642-1648.
77. Levine, J., Taiwo, Y., 1994. Inflammatory pain. In: Wall, P.D., Melzack, R. (Eds.), Textbook of Pain, 3rd ed. Churchill Livingstone, London, pp. 45-56.
78. Li J., Perl E.R. Adenosine inhibition of synaptic transmission in the substantia gelatinose. J. Neurophysiol. 72:1994;1611-1621.
79. López-Muñoz F.J., Castañeda-Hernández G., Flores-Murrieta F.J., Granados-Soto V. Effect of caffeine coadministration and of nitric oxide synthesis inhibition on the antinociceptive action of ketorolac. Eur. J. Pharmacol. 308:1996;275-277.
80. 2 receptors in fentanyl-induced muscular rigidity in the rat. Neurosci. Lett. 224:1997;189-192.
81. MacDonald R.L., Skerritt J.H., Werz M.A. Adenosine agonists reduce voltage-dependent calcium conductance of mouse sensory neurons in cell culture. J. Physiol. 370:1986;75-90.
82. Malec D., Michalska E. The effect of methylxanthines on morphine analgesia in mice and rats. Pol. J. Pharmacol. Pharm. 40:1988;223-232.
83. Malec D., Michalska E. The effect of adenosine receptor agonists on analgesic effects of morphine. Pol. J. Pharmacol. Pharm. 42:1990;1-11.
84. Malmberg A.B., Yaksh T.L. Pharmacology of the spinal action of ketorolac, morphine, ST-91, U50488H and L-PIA on the formalin test and an isobolographic analysis of the NSAID interaction. Anesthesiology. 79:1993;270-281.
85. Marchand S., Li J., Charest J. Effects of caffeine on analgesia from transcutaneous electrical nerve stimulation. N. Engl. J. Med. 333:1995;325-326.
86. Michalska E., Malec D. Agonists and antagonists of adenosine receptors and morphine withdrawal syndrome in rats. Pol. J. Pharmacol. 45:1993;1-9.
87. 2α to conscious mice. Pain. 50:1992;223-229.
88. Misra A.L., Pontani R.B., Vadlamani N.L. Potentiation of morphine analgesia by caffeine. Br. J. Pharmacol. 84:1985;789-791.
89. Möser G.H., Schrader J., Deussen A. Turnover of adenosine in plasma of human and dog blood. Am. J. Physiol. 256 (Cell Physiol. 25):1989;C799-C806.
90. Nakamura I., Ohta Y., Kemmotsu O. Characterization of adenosine receptors mediating spinal sensory transmission related to nociceptive information in the rat. Anesthesiology. 87:1997;577-584.
91. 1-receptors in the primate sensory ganglia and spinal cord. Brain Res. 241:1982;197-206.
92. 2A receptors. Trends Pharmacol. Sci. 17:1996;364-372.
93. Pappagallo M., Gaspardone A., Tomai F., Iamele M., Crea F., Gioffré P.A. Analgesic effect of bamiphylline on pain induced by intradermal injection of adenosine. Pain. 53:1993;199-204.
94. Pardridge W.M., Yoshikawa T., Kang Y.-S., Miller L.P. Blood-brain barrier transport and brain metabolism of adenosine and adenosine analogs. J. Pharmacol. Exp. Ther. 268:1994;14-18.
95. Person D.L., Kissin I., Brown P.T., Xavier A.V., Vinik H.R., Bradley E.L. Morphine-caffeine analgesic interaction in rats. Anesth. Analg. 64:1985;851-856.
96. Phillis J.W. Potentiation of the action of adenosine on cerebral cortical neurones by the tricyclic antidepressants. Br. J. Pharmacol. 83:1984;567-575.
97. Phillis J.W., Wu P.H. The effect of various centrally active drugs on adenosine uptake by the central nervous system. Comp. Biochem. Physiol. 72C:1982;179-187.
98. Pierce P.A., Xie G.X., Levine J.D., Peroutka S.J. 5-Hydroxytryptamine receptor subtype messenger RNAs in rat peripheral sensory and sympathetic ganglia: A polymerase chain reaction study. Neuroscience. 70:1996;553-559.
99. Poon A., Sawynok J. Antinociception by adenosine analogs and an adenosine kinase inhibitor: Dependence on formalin concentration. Eur. J. Pharmacol. 286:1995;177-184.
100. Poon, A., Sawynok, J., 1997. Antinociception by adenosine analogs and inhibitors of adenosine metabolism in an inflammatory thermal hyperalgesia model in the rat. Pain. In press.
101. Portenoy R.K. Drug therapy for neuropathic pain. Drug Ther. 23:1993;41-53.
102. Post C. Antinociceptive effects in mice after intrathecal injection of 5′-N-ethylcarboxamide adenosine. Neurosci. Lett. 51:1984;325-330.
103. 3 adenosine receptor is the unique adenosine receptor which facilitates release of allergic mediators in mast cells. J. Biol. Chem. 268:1993;16887-16890.
104. Reeve A.J., Dickenson A.H. The roles of spinal adenosine receptors in the control of acute and more persistent nociceptive responses of dorsal horn neurones in the anaesthetized rat. Br. J. Pharmacol. 116:1995;2221-2228.
105. Rosengren S., Bong G.W., Firestein G.S. Anti-inflammatory effects of an adenosine kinase inhibitor. Decreased neutrophil accumulation and vascular leakage. J. Immunol. 154:1995;5444-5451.
106. Salter M.W., Henry J.L. Evidence that adenosine mediates the depression of spinal dorsal horn neurons induced by peripheral vibration in the cat. Neuroscience. 22:1987;631-650.
107. Salter M.W., De Koninck Y., Henry J.L. Physiological roles for adenosine and ATP in synaptic transmission in the spinal dorsal horn. Prog. Neurobiol. 41:1993;125-156.
108. 1 receptors mediate the presynaptic inhibition of calcitonin gene-related peptide release by adenosine in the rat spinal cord. Eur. J. Pharmacol. 231:1993;139-142.
109. Sawynok, J., 1997. Purines and nociception. In: Jacobson, K.A., Jarvis, M.F. (Eds.), Purinergic Approaches in Experimental Therapeutics. Wiley and Sons, New York, pp. 495-513.
110. Sawynok J., Reid A. Role of G-proteins and adenylate cyclase in antinociception produced by intrathecal purines. Eur. J. Pharmacol. 156:1988;25-34.
111. Sawynok J., Reid A. Neurotoxin-induced lesions to central serotonergic, noradrenergic and dopaminergic systems modify caffeine-induced antinociception in the formalin test and locomotor stimulation in rats. J. Pharmacol. Exp. Ther. 277:1996;646-653.
112. Sawynok J., Yaksh T.L. Caffeine as an analgesic adjuvant: A review of pharmacology and mechanisms of action. Pharmacol. Rev. 45:1993;43-85.
113. Sawynok J., Sweeney M.I., White T.D. Classification of adenosine receptors mediating antinociception in the rat spinal cord. Br. J. Pharmacol. 88:1986;923-930.
114. Sawynok J., Espey M.J., Reid A. 8-Phenyltheophylline reverses the antinociceptive action of morphine in the periaqueductal gray. Neuropharmacology. 30:1991;871-877.
115. Sawynok J., Reid A.R., Doak G.J. Caffeine antinociception in the rat hot-plate and formalin tests and locomotor stimulation: Involvement of noradrenergic mechanisms. Pain. 61:1995;203-213.
116. Sawynok J., Reid A., Poon A. Peripheral antinociceptive effect of an adenosine kinase inhibitor, with augmentation by an adenosine deaminase inhibitor, in the rat formalin test. Pain. 74:1998;75-81.
117. 3 receptor activation produces nociceptive behaviour and edema by release of histamine and 5-hydroxytryptamine. Eur. J. Pharmacol. 333:1997;1-7.
118. Segerdahl M., Ekblom A., Sollevi A. The influence of adenosine, ketamine and morphine on experimentally induced ischemic pain in healthy volunteers. Anesth. Analg. 79:1994;787-791.
119. Segerdahl M., Ekblom A., Sandelin K., Wickman M., Sollevi A. Peroperative adenosine infusion reduces the requirements for isoflurane and postoperative analgesics. Anesth. Analg. 80:1995;1145-1149.
120. Segerdahl M., Ekblom A., Sjölund K.-F., Belfrage M., Forsberg C., Sollevi A. Systemic adenosine attenuates touch evoked allodynia induced by mustard oil in humans. Neuroreport. 6:1995;753-756.
121. Segerdahl M., Persson E., Ekblom A., Sollevi A. Peroperative adenosine infusion reduces isoflurane concentrations during general anesthesia for shoulder surgery. Acta Anaesth. Scand. 40:1996;792-797.
122. Sierralta F., Pinardi G., Mendez M., Miranda H.F. Interaction of opioids with antidepressant-induced antinociception. Psychopharmacology. 122:1995;374-378.
123. Sjölund K.-F., Sollevi A., Segerdahl M., Hansson P., Lundeberg T. Intrathecal and systemic R-phenylisopropyladenosine reduces scratching behaviour in a rat mononeuropathy model. Neuroreport. 7:1996;1856-1860.
124. Sjölund K.-F., Sollevi A., Segerdahl M., Lundeberg T. Intrathecal adenosine analog administration reduces substance P in cerebrospinal fluid along with behavioral effects that suggest antinociception in rats. Anesth. Analg. 85:1997;627-632.
125. Smart D., Lambert D.G. The stimulatory effects of opioids and their possible role in the development of tolerance. Trends Pharmacol. Sci. 17:1996;264-269.
126. Sollevi A., Belfrage M., Lundeberg T., Segerdahl M., Hansson P. Systemic adenosine infusion: A new treatment modality to alleviate neuropathic pain. Pain. 61:1995;155-158.
127. Sosnowski M., Yaksh T.L. Role of spinal adenosine receptors in modulating the hyperesthesia produced by spinal glycine receptor antagonism. Anesth. Analg. 69:1989;587-592.
128. 2 adenosine receptors mediating the purine antinociception, motor and autonomic function in the rat spinal cord. J. Pharmacol. Exp. Ther. 250:1989;915-922.
129. Stone T.W. The effects of morphine and methionine-enkephalin on the release of purines from cerebral cortex slices of rats and mice. Br. J. Pharmacol. 74:1981;171-176.
130. Stone T.W., Taylor D.A. Antidepressant drugs potentiate suppression by adenosine of neuronal firing in rat cerebral cortex. Neurosci. Lett. 11:1979;93-97.
131. Suh H.W., Song D.K., Kim Y.H. Differential effects of adenosine receptor antagonists injected intrathecally on antinociception induced by morphine and β-endorphin administered intracerebroventricularly in the mouse. Neuropeptides. 31:1997;339-344.
132. Sweeney M.I., White T.D., Sawynok J. Involvement of adenosine in the spinal antinociceptive effects of morphine and noradrenaline. J. Pharmacol. Exp. Ther. 243:1987;657-665.
133. + release purines from capsaicin-sensitive primary afferent nerve terminals in the spinal cord. J. Pharmacol. Exp. Ther. 248:1989;447-454.
134. Sweeney M.I., White T.D., Sawynok J. 5-Hydroxytryptamine releases adenosine and cyclic AMP from primary afferent nerve terminals in the spinal cord in vivo. Brain Res. 528:1990;55-61.
135. Sweeney M.I., White T.D., Sawynok J. Intracerebroventricular morphine releases adenosine and adenosine 3′, 5′-cyclic monophosphate from the spinal cord via a serotonergic mechanism. J. Pharmacol. Exp. Ther. 259:1991;1013-1259.
136. Sweeney M.I., White T.D., Sawynok J. Morphine-evoked release of adenosine from the spinal cord occurs via a nucleoside carrier with differential sensitivity to dipyridamole and nitrobenzylthioinosine. Brain Res. 614:1993;301-307.
137. Sylvén C., Beermann B., Jonzon B., Brandt R. Angina pectoris-like pain provoked by intravenous adenosine in healthy volunteers. Br. Med. J. 293:1986;227-230.
138. Sylvén C., Beermann B., Edlund A., Lewander R., Jonzon B., Mogensen L. Provocation of chest pain in patients with coronary insufficiency using the vasodilator adenosine. Eur. Heart J. 9 (Suppl. N):1988;6-10.
139. Sylvén C., Jonzon B., Fredholm B.B., Kaijser L. Adenosine injection into the brachial artery produces ischemia like pain or discomfort in the forearm. Cardiovasc. Res. 22:1988;674-678.
140. Sylvén C., Beermann B., Kaijser L., Jonzon B. Nicotine enhances angina pectoris-like pain and atrioventricular blockade provoked by intravenous bolus of adenosine in healthy volunteers. J. Cardiovasc. Pharmacol. 16:1990;962-965.
141. Taiwo Y.O., Levine J.D. Direct cutaneous hyperalgesia induced by adenosine. Neuroscience. 38:1990;757-762.
142. Taiwo Y.O., Levine J.D. Further confirmation of the role of adenyl cyclase and of cAMP-dependent protein kinase in primary afferent hyperalgesia. Neuroscience. 44:1991;131-135.
143. 1 receptors in rats. Eur. J. Pharmacol. 215:1992;301-304.
144. 1 receptors in rats. Eur. J. Pharmacol. 278:1995;233-237.
145. Vapaatalo H., Onken D., Neuvonen P.J., Westermann E. Stereospecificity in some central and circulatory effects of phenylisopropyl-adenosine (PIA). Arzneim. Forsch. 25:1975;407-410.
146. Watt A.H., Lewis D.J.M., Horne J.J., Smith P.M. Reproduction of epigastric pain of duodenal ulceration by adenosine. Br. Med. J. 294:1987;10-12.
147. White P.J., Hope W., Rose'Meyer R.B. The role of adenosine in the hypotensive actions of morphine. Eur. J. Pharmacol. 286:1995;315-319.
148. 3H -purines from rat brain cerebral cortical prisms Pharmacol. Biochem. Behav. 17:1982;749-755.
149. Yamamoto T., Yaksh T.L. Spinal pharmacology of thermal hyperesthesia induced by incomplete ligation of sciatic nerve. Anesthesiology. 75:1991;817-826.
150. Yang S.-W., Zhang Z.-H., Chen J.-Y., Xie Y.-F., Qiao J.-T., Dafny N. Morphine and norepinephrine-induced antinociception at the spinal level is mediated by adenosine. NeuroReport. 5:1994;1441-1444.
151. Yang S.-W., Chen J.-Y., Zhang Z.-H., Xie Y.-F., Qiao J.-T., Dafny N. Adenosine and opiate-like substances mediates antinociception at the spinal cord. Brain Res. 673:1995;170-174.
152. Yarbrough G.C., McGuffin-Clineschmidt J.C. In vivo behavioral assessment of central nervous system purinergic receptors. Eur. J. Pharmacol. 76:1981;137-144.